Generate a tailored SOP for Dr. Paul Freemont. Improve your application with a focused, well-structured draft.
Paul Freemont is a Professor and Head of the Structural Synthetic Biology Section in the Department of Infectious Disease at Imperial College London. His research focuses on the molecular mechanisms of human disease and infection through integrated structural biology tools. His work includes notable research programs in synthetic biology, emphasizing automation, cell-free systems, microbiome engineering, and 3D printing. Freemont co-founded the Imperial College Centre for Synthetic Biology and co-directs the UK National Innovation Knowledge Centre. He is also the Director of the London Biofoundry. His research interests lie in developing foundational tools for synthetic biology, including biofoundries and applications in biosensing, metabolic engineering, and synthetic cells. He has authored over 300 scientific publications and has received numerous accolades, including being elected a member of the European Molecular Biology Organization and a Fellow of multiple prestigious institutions. As a leading voice in the field, he participates in various councils and groups, including the Engineering Biology Research Consortium and the UK government's Engineering Biology Steering Group, and advocates for the commercialization of engineering biology.
Imperial College London • London, United Kingdom
Leading research and development in the field of structural synthetic biology.
Imperial College London • London, United Kingdom
Oversaw research within the section, focusing on structural biology pertinent to infectious diseases.
UK National Innovation Knowledge Centre Synthetic Biology • United Kingdom
Contributing to the development and innovation in synthetic biology across the UK.
London Biofoundry • United Kingdom
Managing operations and strategic direction of the biofoundry.
Imperial College London • United Kingdom
Led the division focused on molecular biosciences.
Imperial College London • United Kingdom
Directed the center's research and collaborations.
Imperial Cancer Research Fund • London, United Kingdom
Conducted pivotal research in cancer biology.
Imperial Cancer Research Fund • London, United Kingdom
Focused on cancer research initiatives.
Imperial Cancer Research Fund • London, United Kingdom
Investigated structural biology in cancer research.
Yale University • New Haven, United States
Engaged in advanced studies in molecular biophysics and biochemistry.
Specialisms available in Materials for the Energy Transition or Theory and Simulation of Materials.